Elvanse and Heart Health: Blood Pressure, Pulse and Cardiovascular Screening in the UK
Elvanse is a stimulant medicine used to treat attention deficit hyperactivity disorder (ADHD). Because it can increase blood pressure and heart rate, cardiovascular screening and regular monitoring are important parts of safe prescribing in the UK.
For most people, the changes in blood pressure and pulse are modest. However, some people may have a higher risk of cardiovascular complications, particularly if they have existing heart disease, uncontrolled hypertension, concerning symptoms or a relevant family history. UK prescribing information states that blood pressure and pulse should be checked at baseline, after dose adjustments and at least every six months during treatment.
This guide explains how Elvanse may affect the heart, what cardiovascular checks involve, when an ECG or cardiology referral may be considered, and when to seek urgent medical help.
Important: This article is for general information and does not replace advice from your GP, ADHD specialist, pharmacist or cardiologist. Do not start, stop or change Elvanse without speaking to the clinician responsible for your care.
What is Elvanse?
Elvanse contains lisdexamfetamine dimesylate, a stimulant medicine used as part of a comprehensive ADHD treatment programme. The body converts lisdexamfetamine into dexamfetamine, which affects chemicals involved in attention, concentration and impulse control.
Elvanse is taken once daily, usually in the morning. The medicine can improve ADHD symptoms, but it may also stimulate the cardiovascular system. This means it can raise blood pressure or increase pulse in some people.
The UK Summary of Product Characteristics reports that stimulant medicines cause an average increase of approximately 2–4 mmHg in blood pressure and 3–6 beats per minute in heart rate, although individual responses can be larger.
A small average change does not mean monitoring is unnecessary. Your clinician needs to identify any significant increase and consider whether the medicine remains suitable for you.
How Elvanse affects heart health
Elvanse may influence cardiovascular measurements in several ways:
Blood pressure may rise.
Resting pulse may increase.
Palpitations or awareness of the heartbeat may occur.
Existing heart conditions may become more clinically significant.
Rarely, serious heart rhythm or cardiovascular problems may develop.
Many people can take stimulant medication safely when they have been appropriately assessed and monitored. The purpose of cardiovascular screening is not to prevent everyone from receiving treatment. It is to identify situations where a different medicine, closer observation, further investigation or specialist advice may be needed.
The decision to prescribe should consider the potential benefits of improving ADHD symptoms alongside any cardiovascular risks.
Cardiovascular screening before Elvanse
Before prescribing Elvanse, a clinician should review your physical health and cardiovascular history. This assessment usually includes questions, measurements and a physical examination where appropriate.
Medical history
Your clinician may ask whether you have:
High blood pressure.
Heart disease or previous cardiac surgery.
An irregular heartbeat or diagnosed arrhythmia.
Heart failure or cardiomyopathy.
A previous heart attack.
Episodes of fainting or unexplained collapse.
Chest pain, particularly during exercise.
Breathlessness that is unusual for you.
Rapid or sudden-onset palpitations.
A known inherited heart condition.
Tell your prescriber about any previous diagnosis, even if it has not caused recent symptoms.
Family history
Family history can be important. Your clinician may ask whether a close relative had:
Sudden cardiac death at a young age.
An unexplained death before 40.
An inherited rhythm disorder.
Cardiomyopathy.
Long QT syndrome or another inherited cardiac condition.
A concerning family history does not automatically mean that Elvanse cannot be prescribed. It may mean that additional assessment or cardiology advice is appropriate before treatment begins.
Blood pressure
Blood pressure should be measured before treatment. If it is significantly raised, your clinician may investigate or manage the hypertension before considering a stimulant.
Elvanse is contraindicated in people with moderate to severe hypertension according to the UK product information. It also requires caution in people whose underlying conditions could be worsened by an increase in blood pressure.
One high reading does not always confirm hypertension. Blood pressure can temporarily rise because of stress, caffeine, pain, recent exercise or an unsuitable measurement technique. Your clinician may repeat the reading or arrange home or ambulatory monitoring.
Pulse and heart rhythm
Your resting pulse should also be checked before treatment. A persistently fast or irregular pulse may require further assessment.
Tell your clinician if you regularly notice:
A racing heartbeat.
Fluttering or pounding in the chest.
A pulse that feels irregular.
Sudden episodes that start and stop.
Dizziness or near-fainting with palpitations.
Occasional awareness of the heartbeat can have many causes, but new or persistent palpitations should not be dismissed.
Weight and general health
Although weight is not a cardiovascular test, it forms part of routine ADHD medication monitoring. Appetite suppression and weight loss can affect general health, energy and wellbeing.
For children and young people, height and weight should be monitored because stimulant treatment may affect appetite and growth. NICE recommends monitoring cardiovascular status, weight and growth during ADHD treatment.
Is an ECG required before Elvanse?
An electrocardiogram (ECG) records the electrical activity of the heart. It may detect some rhythm abnormalities or electrical patterns that require further investigation.
An ECG is not routinely required before starting ADHD medication when the cardiovascular history and examination are unremarkable. However, an ECG or cardiology referral may be considered if there are relevant symptoms, a concerning medical or family history, abnormal examination findings or other clinical reasons.
Examples of situations that may require further assessment include:
Exertional chest pain.
Unexplained fainting.
Rapid, regular and sudden-onset palpitations.
A known congenital heart condition.
A heart murmur.
Signs of heart failure.
A family history of sudden death at a young age.
Known arrhythmia or cardiomyopathy.
Local NHS prescribing protocols may vary, so the exact process depends on your circumstances and the clinician responsible for prescribing. An ECG should not be used as a substitute for a careful history, examination and ongoing monitoring.
Monitoring during Elvanse treatment
Cardiovascular monitoring continues after Elvanse is started. UK product information recommends recording blood pressure and pulse at each dose adjustment and at least every six months thereafter. For children, readings may be plotted on an age- and height-related centile chart.
Your monitoring schedule may be more frequent if:
Your dose is being increased.
Your blood pressure is elevated.
You have a heart condition or other cardiovascular risk.
You develop symptoms.
You take other medicines that affect blood pressure or heart rhythm.
You have recently changed lifestyle factors, such as caffeine intake or intense exercise.
Your clinician is investigating a new concern.
Monitoring should assess both numbers and symptoms. A normal blood pressure reading does not completely rule out a heart problem if you have chest pain, fainting, breathlessness or significant palpitations.
Understanding blood pressure readings
Blood pressure is recorded as two numbers:
Systolic pressure: the pressure when the heart contracts.
Diastolic pressure: the pressure when the heart relaxes between beats.
Readings can vary throughout the day. To improve accuracy, avoid measuring immediately after exercise, smoking or caffeine. Sit quietly for several minutes, keep your feet flat on the floor and support your arm at heart level.
If you are checking your blood pressure at home, take readings according to your clinician’s instructions and record the date, time, pulse and symptoms. Do not repeatedly check because you feel anxious unless a healthcare professional has recommended a specific monitoring plan.
Your prescriber will interpret the reading in context. Factors such as age, existing hypertension, pregnancy, other medicines and the measurement setting can affect what happens next.
What if blood pressure or pulse increases?
A rise in blood pressure or pulse does not necessarily mean that Elvanse must be stopped immediately. Your clinician may:
Repeat the measurement.
Review how the reading was taken.
Ask about caffeine, nicotine, sleep, stress and other medicines.
Check adherence and dose timing.
Review the Elvanse dose.
Investigate possible hypertension or an arrhythmia.
Consider a dose reduction or alternative ADHD treatment.
Seek specialist advice.
Do not reduce or stop your medication independently. Abrupt changes may affect ADHD symptom control and can make it harder to understand what is causing a symptom.
The UK product information advises monitoring for larger-than-average changes. It also states that lisdexamfetamine is contraindicated in symptomatic cardiovascular disease and moderate to severe hypertension.
Symptoms that need urgent attention
Contact your doctor promptly if you develop new or persistent:
Palpitations or an irregular heartbeat.
A consistently fast resting pulse.
Dizziness associated with a racing heartbeat.
Breathlessness that is new or worsening.
Reduced exercise tolerance.
Swelling in the legs.
Unexplained fainting or near-fainting.
Chest discomfort, especially during exertion.
The Elvanse patient information leaflet advises patients to inform their doctor immediately if they experience palpitations or an irregular heartbeat.
Call 999 or attend A&E if you have severe or persistent chest pain, collapse, severe breathlessness, a sustained very fast or irregular heartbeat, or symptoms suggesting a heart attack or another emergency.
Do not drive yourself to hospital if you feel faint, severely unwell or unsafe.
Supporting cardiovascular health while taking Elvanse
Medication monitoring is important, but everyday factors can also affect blood pressure and pulse.
Helpful steps include:
Take Elvanse exactly as prescribed.
Take it at the prescribed time, usually in the morning.
Avoid taking extra doses.
Tell your clinician about caffeine, nicotine, alcohol, supplements and recreational drugs.
Maintain regular meals and adequate hydration.
Prioritise consistent sleep.
Build physical activity gradually and follow medical advice if you have a heart condition.
Attend scheduled medication reviews.
Keep a record of symptoms and home readings if monitoring has been advised.
Some medicines and substances can increase cardiovascular stimulation or interact with ADHD treatment. Always check with a pharmacist before starting a new medicine or supplement.
Frequently asked questions
Does Elvanse raise blood pressure?
It can. Average increases are usually modest, but some individuals experience a more significant rise. Blood pressure should be checked before treatment, after dose changes and at least every six months during ongoing treatment.
Does Elvanse increase heart rate?
Elvanse may increase pulse or cause palpitations. The reported average increase in heart rate is approximately 3–6 beats per minute, although individual responses vary. Report a persistently fast, irregular or symptomatic heartbeat to your clinician.
Can I take Elvanse if I have high blood pressure?
It depends on the severity and control of your hypertension. Moderate to severe hypertension is listed as a contraindication in the UK product information. Your clinician may need to assess and manage your blood pressure before considering ADHD medication.
Do I need an ECG before starting Elvanse?
Not everyone needs an ECG. It may be recommended if you have symptoms, a relevant family history, a known heart condition, an abnormal examination or another clinical reason. Your prescriber will decide whether further cardiac assessment is necessary.
Can Elvanse cause heart problems in healthy adults?
Serious cardiovascular complications are uncommon, but no medicine is risk-free. Screening and monitoring help identify people who may need additional assessment. Seek urgent help for chest pain, fainting, severe breathlessness or a sustained irregular heartbeat.
Should I check my pulse at home?
Not everyone needs to check their pulse daily. If your clinician advises home monitoring, follow their instructions and record your results alongside symptoms, medication timing, caffeine and exercise. Contact your healthcare professional if readings are persistently abnormal or associated with symptoms.
Can caffeine make Elvanse-related heart symptoms worse?
Caffeine can contribute to a fast heartbeat, jitteriness, anxiety or sleep problems in some people taking stimulants. If you notice symptoms after coffee, energy drinks or pre-workout products, reduce or avoid them and discuss this with your clinician.
Can I exercise while taking Elvanse?
Many people can exercise safely, but your advice should be personalised if you have cardiovascular disease, symptoms or abnormal monitoring results. Stop exercising and seek medical advice if you develop chest pain, fainting, severe breathlessness or unusual palpitations.
Book an ADHD assessment
Understanding your heart health is an important part of safe ADHD treatment, but it is only one part of a complete assessment. A qualified clinician can review your ADHD symptoms, medical history, current medicines, cardiovascular risk factors and treatment goals.
If you think you may have ADHD, or you want a professional review of your symptoms and treatment options, book an ADHD assessment with Focus Gently.
Visit Focus Gently to learn more about ADHD assessment and support. Taking this step can help you understand your options and move towards a treatment plan that considers both symptom improvement and your wider health.
